Back to search

Article

Bone metastasis unique plasma exosomal microRNA signature in non-small cell lung cancer

2020-04-22

Abstract excerpt

<h4>Background: </h4> 20–40% of lung cancer patients develop bone metastasis (BM) with significantly decreased overall survival. Currently, BM is mainly diagnosed by CT scan or MRI when symptom develops. Novel biomarkers with higher prediction value of BM are needed. Methods Prospective analysis was undertaken on non-small cell lung cancer (NSCLC) patients with (BM+) and without BM (BM-). Plasma exosomal RNA was...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2f5225f5-3620-54f7-9bd8-dca84f6f316b
DOI
10.21203/rs.3.rs-23619/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bone metastasis unique plasma exosomal microRNA signature in non-small cell lung cancerDOI 10.21203/rs.3.rs-23619/v1
Select a neighboring publication to make it the new centre.